Zeng L - Search Results

1

Translation Rescue by Targeting Ppp1r15a through Its Upstream Open Reading Frame in Sepsis-Induced Acute Kidney Injury in a Murine Model.

Kidwell A, Yadav SPS, Maier B, Zollman A, Ni K, Halim A, Janosevic D, Myslinski J, Syed F, Zeng L, Waffo AB, Banno K, Xuei X, Doud EH, Dagher PC, Hato T. Kidwell A, et al. Among authors: zeng l. J Am Soc Nephrol. 2023 Feb 1;34(2):220-240. doi: 10.1681/ASN.2022060644. Epub 2022 Oct 31. J Am Soc Nephrol. 2023. PMID: 36283811 Free PMC article.

2

Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.

Liu S, Zeng LF, Wu L, Yu X, Xue T, Gunawan AM, Long YQ, Zhang ZY. Liu S, et al. Among authors: zeng lf. J Am Chem Soc. 2008 Dec 17;130(50):17075-84. doi: 10.1021/ja8068177. J Am Chem Soc. 2008. PMID: 19012396 Free PMC article.

3

Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.

Bai Y, Yu ZH, Liu S, Zhang L, Zhang RY, Zeng LF, Zhang S, Zhang ZY. Bai Y, et al. Among authors: zeng lf. Cancer Res. 2016 Aug 15;76(16):4805-15. doi: 10.1158/0008-5472.CAN-15-2323. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325652 Free PMC article.

4

Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma.

Xu J, Zeng LF, Shen W, Turchi JJ, Zhang ZY. Xu J, et al. Biochem Biophys Res Commun. 2013 Oct 4;439(4):586-90. doi: 10.1016/j.bbrc.2013.09.028. Epub 2013 Sep 13. Biochem Biophys Res Commun. 2013. PMID: 24041688 Free PMC article.

5

Therapeutic potential of targeting the oncogenic SHP2 phosphatase.

Zeng LF, Zhang RY, Yu ZH, Li S, Wu L, Gunawan AM, Lane BS, Mali RS, Li X, Chan RJ, Kapur R, Wells CD, Zhang ZY. Zeng LF, et al. J Med Chem. 2014 Aug 14;57(15):6594-609. doi: 10.1021/jm5006176. Epub 2014 Jul 28. J Med Chem. 2014. PMID: 25003231 Free PMC article.

6

Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS.

Lam AK, Zhang J, Frabutt D, Mulcrone PL, Li L, Zeng L, Herzog RW, Xiao W. Lam AK, et al. Among authors: zeng l. Mol Ther Methods Clin Dev. 2022 Sep 24;27:185-194. doi: 10.1016/j.omtm.2022.09.008. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36284765 Free PMC article.

7

Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.

Sharma N, Everingham S, Zeng LF, Zhang ZY, Kapur R, Craig AW. Sharma N, et al. Oncotarget. 2014 Aug 15;5(15):6130-41. doi: 10.18632/oncotarget.2177. Oncotarget. 2014. PMID: 25026279 Free PMC article.

8

The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.

Nabinger SC, Li XJ, Ramdas B, He Y, Zhang X, Zeng L, Richine B, Bowling JD, Fukuda S, Goenka S, Liu Z, Feng GS, Yu M, Sandusky GE, Boswell HS, Zhang ZY, Kapur R, Chan RJ. Nabinger SC, et al. Among authors: zeng l. Leukemia. 2013 Feb;27(2):398-408. doi: 10.1038/leu.2012.308. Epub 2012 Oct 22. Leukemia. 2013. PMID: 23103841 Free PMC article.

9

Small molecule tools for functional interrogation of protein tyrosine phosphatases.

He R, Zeng LF, He Y, Zhang S, Zhang ZY. He R, et al. FEBS J. 2013 Jan;280(2):731-50. doi: 10.1111/j.1742-4658.2012.08718.x. Epub 2012 Aug 16. FEBS J. 2013. PMID: 22816879 Free PMC article. Review.

10

SHP2 phosphatase as a novel therapeutic target for melanoma treatment.

Zhang RY, Yu ZH, Zeng L, Zhang S, Bai Y, Miao J, Chen L, Xie J, Zhang ZY. Zhang RY, et al. Among authors: zeng l. Oncotarget. 2016 Nov 8;7(45):73817-73829. doi: 10.18632/oncotarget.12074. Oncotarget. 2016. PMID: 27650545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,203 results

Search Page